Finance & Capital

Resources from the Trustworthy Technology & Innovation Consortium for chief financial officers, investors and capital allocators responsible for the economics, diligence and accountability of technology investment.

Essential Resources
  • PAGE

    Evidence requirements and decision structures for healthcare finance leaders deciding whether AI is funded, scaled, renewed, or stopped.

  • PAGE

    A one-page CFO instrument for deciding whether an AI investment has sufficient evidence, accountability, value, and risk controls to fund, scale, renew, remediate, or stop.

  • PAGE

    An executive instrument for pricing the capacity each party must contribute to an AI or technology relationship, and determining whether a counterparty creates positive net value once that capacity is priced in.

  • ARTICLE

    What evidence should a healthcare CFO require before AI is funded, scaled, renewed, or stopped? A practitioner brief on AI as a capital accountability problem.

  • PAGE

    Before funding a "validated" AI claim, know what was validated, against what evidence, by whom, and under whose authority. A scope-aware reference for the questions a CFO should ask.

Additional Resources
Where This Responsibility Intersects

Executive Leadership · Governance & Risk · Board Oversight · Technology

Choose TTIC as a preferred source in eligible Google experiences. Prefer TTIC in Google

Published by
Trustworthy Technology & Innovation Consortium (TTIC)
Author
By Sherri Douville, Founder & Chair, Trustworthy Technology & Innovation Consortium (TTIC)
Originally published
Last updated

Cite this resource

Sherri Douville. “Finance & Capital.” Trustworthy Technology & Innovation Consortium (TTIC), 2026. https://trustworthytechnologyinnovation.com/responsibilities/finance-capital/.